Ortivus AB ser. B Asset Resilience Ratio
Ortivus AB ser. B asset resilience ratio. Ortivus AB ser. B (ORTI-B) has an Asset Resilience Ratio of 12.53% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See defensive interval ratio of Ortivus AB ser. B to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of Ortivus AB ser. B (2005–2025)
Asset resilience ratio of Ortivus AB ser. B from 2005 to 2025. This chart shows how Ortivus AB ser. B's Asset Resilience Ratio has changed over time. Read Ortivus AB ser. B balance sheet liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down Ortivus AB ser. B's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see balance sheet size of Ortivus AB ser. B.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Skr8.89 Million | 12.53% |
| Short-term Investments | Skr0.00 | 0% |
| Total Liquid Assets | Skr8.89 Million | 12.53% |
Asset Resilience Insights
- Moderate Liquidity: Ortivus AB ser. B has 12.53% of assets in liquid form.
- While adequate for normal operations, this level may limit flexibility during economic stress.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Ortivus AB ser. B Industry Peers by Asset Resilience Ratio
Compare Ortivus AB ser. B's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Caina Technology Co. Ltd.
SHE:301122 |
Medical Instruments & Supplies | 19.55% |
|
Austco Healthcare Ltd
AU:AHC |
Medical Instruments & Supplies | 15.90% |
|
Nyxoah
BR:NYXH |
Medical Instruments & Supplies | 12.40% |
|
Ocumetics Technology Corp
V:OTC |
Medical Instruments & Supplies | 0.00% |
|
Osteopore Ltd
AU:OSX |
Medical Instruments & Supplies | 22.60% |
|
Ansell Ltd
AU:ANN |
Medical Instruments & Supplies | 7.53% |
|
Nanosonics Ltd
AU:NAN |
Medical Instruments & Supplies | 46.84% |
|
SDI Ltd
AU:SDI |
Medical Instruments & Supplies | 3.36% |
Ortivus AB ser. B Asset Resilience Ratio by Year (2005–2025)
Ortivus AB ser. B asset resilience ratio by year from 2005 to 2025. The table below shows the annual Asset Resilience Ratio data for Ortivus AB ser. B.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 12.53% | Skr8.89 Million ≈ $956.49K |
Skr70.93 Million ≈ $7.63 Million |
+1.14pp |
| 2024-12-31 | 11.39% | Skr7.28 Million ≈ $783.55K |
Skr63.91 Million ≈ $6.88 Million |
+9.62pp |
| 2023-12-31 | 1.77% | Skr1.29 Million ≈ $138.72K |
Skr72.71 Million ≈ $7.82 Million |
-6.69pp |
| 2022-12-31 | 8.46% | Skr7.60 Million ≈ $817.56K |
Skr89.75 Million ≈ $9.66 Million |
-22.05pp |
| 2021-12-31 | 30.52% | Skr22.11 Million ≈ $2.38 Million |
Skr72.46 Million ≈ $7.80 Million |
-4.98pp |
| 2020-12-31 | 35.50% | Skr23.62 Million ≈ $2.54 Million |
Skr66.55 Million ≈ $7.16 Million |
+10.63pp |
| 2019-12-31 | 24.87% | Skr8.69 Million ≈ $935.08K |
Skr34.94 Million ≈ $3.76 Million |
+12.52pp |
| 2018-12-31 | 12.34% | Skr3.42 Million ≈ $367.94K |
Skr27.70 Million ≈ $2.98 Million |
+7.19pp |
| 2017-12-31 | 5.16% | Skr1.78 Million ≈ $191.66K |
Skr34.54 Million ≈ $3.72 Million |
-0.88pp |
| 2016-12-31 | 6.03% | Skr2.85 Million ≈ $306.81K |
Skr47.25 Million ≈ $5.08 Million |
+5.28pp |
| 2009-12-31 | 0.75% | Skr1.24 Million ≈ $133.34K |
Skr164.13 Million ≈ $17.66 Million |
+0.01pp |
| 2008-12-31 | 0.75% | Skr1.35 Million ≈ $145.82K |
Skr181.28 Million ≈ $19.51 Million |
-2.48pp |
| 2007-12-31 | 3.23% | Skr8.19 Million ≈ $881.16K |
Skr253.45 Million ≈ $27.27 Million |
+0.90pp |
| 2006-12-31 | 2.33% | Skr7.80 Million ≈ $838.97K |
Skr333.90 Million ≈ $35.93 Million |
-0.57pp |
| 2005-12-31 | 2.91% | Skr10.36 Million ≈ $1.11 Million |
Skr356.27 Million ≈ $38.34 Million |
-- |
About Ortivus AB ser. B
Ortivus AB (publ) develops and commercializes medical technology solutions and e-health for healthcare industry in Sweden and internationally. The company offers MobiMed Monitor that monitor and shares vital signs and ECG; MobiMed ePR, an electronic patient record system for documentation of treatment and events; MobiMed enRoute, a navigation, case management, and mass casualty management; MobiMe… Read more